why choose us

First received: August 15, 2022

Clinical Trial: The RECOVER IV Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: ST-segment Elevation Myocardial Infarction (STEMI)

Study Type: INTERVENTIONAL


Official Title: Early Impella® Support in Patients With ST-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock: The RECOVER IV Trial

Brief Summary: The purpose of this study is to assess whether hemodynamic support with an Impella-based treatment strategy initiated prior to percutaneous coronary intervention (PCI) in patients with ST-Segment Elevation Myocardial Infarction (STEMI)-Cardiogenic Shock (CS) improves survival and functional outcomes compared to a non-Impella-based treatment strategy.

Read more